期刊文献+

医院内革兰阴性杆菌的分布及其耐药性分析 被引量:1

Analysis of distribution and drug resistance of Gram-negative bacteria in the hospital
下载PDF
导出
摘要 目的分析医院内革兰阴性杆菌的分布及其耐药状况,为临床合理用药提供依据。方法对该院检出的441株革兰阴性杆菌采用细菌编码鉴定及药敏分析系统测试板进行鉴定与微生物敏感性试验。结果在分离的革兰阴性杆菌中,以大肠埃希菌、肺炎克雷伯菌、鲍氏不动杆菌和铜绿假单胞菌4种细菌为主。大肠埃希菌在尿液、腹腔引流液及血液标本中分离率较高;肺炎克雷伯菌、鲍氏不动杆菌和铜绿假单胞菌在痰液标本中的分离率较高。大肠埃希菌产生超广谱β-内酰胺酶(ESBL)的百分比为60.7%,显著高于肺炎克雷伯菌(19.0%)。耐药性由高到低依次为大肠埃希菌、鲍氏不动杆菌、肺炎克雷伯菌和铜绿假单胞菌。结论加强对临床分离的主要病原菌的耐药性监测有利于抗菌药物的合理使用,减缓多重耐药菌株的出现。 Objective To analyze the distribution and drug resistance of Gram-negative bacilli in hospital and to provide a basis for rational drug use clinically.Methods Identification and microbial sensitivity tests were performed upon 441 Gram-negative bacilli isolated from the hospital by bacterial coding identification and drug susceptibility analysis system test board.Results Among Gram-negative bacilli isolated,Escherichia coli,Klebsiella pneumoniae,Acinetobacter baumannii and Pseudomonas aeruginosa were the four major bacteria.Escherichia coli from urine,abdominal drainage fluid,blood samples,and Klebsiella pneumoniae,Acinetobacter baumannii,Pseudomonas aeruginosa from sputum samples showed higher isolating rates.Percentage of extended-spectrum β-lactamase(ESBL) produced by Escherichia coli was 60.7%,which was higher than that of Klebsiella pneumoniae(19.0%).Top-ranked drug resistance in descending order were of Escherichia coli,Klebsiella pneumoniae,Acinetobacter baumannii and Pseudomonas aeruginosa.Conclusion Enhancement of monitoring drug resistance of main pathogens isolated clinically is conducive to rational use of antimicrobial drugs and retarding the emergence of multi-resistant strains.
作者 陈芳 李江
出处 《国际检验医学杂志》 CAS 2013年第9期1106-1107,1109,共3页 International Journal of Laboratory Medicine
关键词 革兰阴性杆菌 抗药性 微生物 微生物敏感性试验 医院 Gram-positive rods drug resistance,microbial microbial sensitivity tests hospital
  • 相关文献

参考文献6

二级参考文献22

  • 1李蓉,李文林,石小玉,梁朝,徐小文,赵林.鲍曼不动杆菌OXA-23型碳青霉烯酶基因的研究[J].中国抗生素杂志,2007,32(2):123-124. 被引量:14
  • 2Arias CA,Murray BE.Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J].N Engl J Med,2009,360(5):439-443.
  • 3Clinical and Laboratory Standads Institute.Performance Standards for Antimicrobial Susceptibility Testing[S].Fifteenth Informational Supplement,2010,M100-S20 Vol 30 No.1.
  • 4Clinical and Laboratory Standads Institute Performance Standards for Antimicrobial Susceptibility Testing[S].Fifteenth Informational Supplement,2010,M100-S20-U Vol 30 No 15.
  • 5Clinical Laboratory Standard Institute.Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria[S].Approved Guideline M45-A,Vol.26 No.19,2006.
  • 6Wang P,Hu FP,Xiong ZZ,et al.Susceptibility of ESBL-Producing nterobacteriaceae with the New CLSI Breakpoints[J].J Clin Microbiol,2011,49(6):3127-3131.
  • 7Yang Q,Wang H,Sun H,et al.Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems:results from large hospital-based surveillance studies in China[J].Antimicrob Agents Chemother,2010,54(1):573-577.
  • 8Wang H.Guo P,Sun HL,et al.Molecular epidemiology of clinical isolates of carbapenem-resistant Acinerobacter spp from Chinese hospitals[J].Antimicrob Agents Chemother.2007,51(11):4022-4028.
  • 9Soto AM, Sonnenschein C, Chung KL. The E-screen assay as a tool to identify estrogens:An update on estrogenic environmental pollutants[J]. Environ Health Perspect, 1995, 103:113-122.
  • 10沈继录,朱德妹,吴卫红,徐晓刚,王明贵.革兰阴性杆菌碳青霉烯酶产生与细菌耐药性关系的研究[J].中华检验医学杂志,2008,31(4):408-414. 被引量:66

共引文献709

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部